Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mako Surgical Corp. (MAKO), Heckmann Corporation (HEK) & Groupon Inc (GRPN): Why You Shouldn’t Worry This Week

MAKO Surgical Corp. (NASDAQ:MAKO)It’s not a perfect world out there for investors, but things may be starting to get better.

The major market indexes rose sharply last week, and investors are starting to realize that this earnings season may not be so bad after all.

I recently went over some of the companies that are expected to post lower quarterly profits when they report this week. Thankfully, they’re the exceptions and not the rule.

Let’s go over some publicly traded companies that are expected to stand tall this week by posting year-over-year improvement on the bottom line.

Company Latest Quarter EPS (estimated) Year-Ago Quarter EPS
MAKO Surgical Corp. (NASDAQ:MAKO) ($0.19) ($0.28)
Heckmann Corporation (NYSE:HEK) ($0.01) ($0.02)
Sodastream International Ltd (NASDAQ:SODA) $0.54 $0.48
Groupon Inc (NASDAQ:GRPN) $0.03 $0.02
Dendreon Corporation (NASDAQ:DNDN) ($0.48) ($0.70)

Source: Thomson Reuters.

Clearing the table
Let’s start at the top with MAKO Surgical Corp. (NASDAQ:MAKO). The leading player in orthopedic robotics took a hit last year as sales for its RIO platform slowed. It didn’t seem to matter that those who had a RIO system in place were actually using them at a heady clip. The market ignored the validation, choosing instead to fret about cash-strapped hospitals and health care facilities scaling back on new installations.

Well, analysts see MAKO Surgical Corp. (NASDAQ:MAKO)’s revenue climbing 26% when it reports tomorrow. They also see the company’s quarterly deficit narrowing.

Heckmann Corporation (NYSE:HEK) is doing more than cleaning up fracking water these days. The environmental services provider expects shareholders to vote at Wednesday’s shareholder meeting to change the company’s name to Nuverra Environmental Solutions. It would then begin trading under the new ticker symbol NES next week.

Last year’s acquisitions of Power Fuels and Thermo Fluids have helped revenue more than double, and after it surprised investors with a quarterly profit last time out, the same pros see a narrowing loss this time around.

Sodastream International Ltd (NASDAQ:SODA)’s popping these days, as the global popularity of its namesake soda-making system grows. Skeptics who wrote off the Israeli company as the maker of a faddish novelty product have had to tweak their bearish arguments, and major beverage brands have been teaming up on licensing deals to put out Sodastream International Ltd (NASDAQ:SODA) flavors.

Sodastream International Ltd (NASDAQ:SODA) has been a pretty consistent beater of Wall Street’s profit targets since going public three years ago, so it wouldn’t be a surprise if it manages to grow its bottom line by more than the 13% clip that analysts are forecasting this time around.

Groupon Inc (NASDAQ:GRPN) isn’t dead, despite general sluggishness in its flagship daily-deals model. The fallen dot-com darling may be trading well below its 2011 IPO price of $20, but Groupon Inc (NASDAQ:GRPN)’s been able to expand its breadth of services to the local merchants that it’s been servicing.

Analysts see an uptick in profitability and a modest gain in revenue.

Finally, we have Dendreon Corporation (NASDAQ:DNDN). The drugmaker behind Provenge — an expensive yet intriguing treatment for late-stage prostate cancer — excited investors with a sequential uptick in its flagship drug in its most recent quarter, but it did warn of softness for the quarter that it will be reporting on come Thursday.

Wall Street’s holding out for a narrowing quarterly loss, though naturally it will also want to know which way Provenge sales have been trending.

Cross those fingers, but know the fundamentals
Investors in these five stocks have a right to be excited. They are all improving their financial situations. They are worthy of the gains that the market rally has bestowed upon them over the past year.

I wouldn’t be uncomfortable owning any of these companies. They’re doing the right thing, regardless of Mr. Market’s mood swings.

The expectations may be high, but these five stocks wouldn’t have it any other way.

The article 5 Reasons Not to Worry This Week originally appeared on Fool.com.

Longtime Fool contributor Rick Munarriz owns shares of Sodastream International Ltd (NASDAQ:SODA). The Motley Fool recommends MAKO Surgical Corp. (NASDAQ:MAKO) and SodaStream. The Motley Fool owns shares of Dendreon Corporation (NASDAQ:DNDN), Heckmann Corporation (NYSE:HEK), and SodaStream and has the following options: Long Jan 2014 $4 Calls on Heckmann and Short Jan 2014 $3 Puts on Heckmann Corporation (NYSE:HEK).

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...